AbbVie Inc. insider buying and selling
3 Form 4 filings against AbbVie Inc. (ABBV) in the last 90 days. Below are the transactions from 3 recent filings, one per insider where the window allows, as filed.
| Date | Insider | Role | Transaction | Code | Shares | Price | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | option exercise | M | 32,710 | $79.02 | 107,140 |
| 2026-08-14 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | open-market sale | S | 32,710 | $250.00 | 74,430 |
What the filings show
Across the 3 filings read here, 1 insider at AbbVie Inc. (ABBV) reported 1 open-market sale of 32,710 shares worth about $8.2M.
The largest by value was Donoghoe Nicholas (EVP, CHIEF BUS/STRAT OFFICER), with about $8.2M sold on the open market.
The Form 4 flow against AbbVie Inc., parsed and explained
The free view above is the newest few filings. The paid report reads the newest Form 4 filings of the last 90 days (up to 100), separates open-market buys and sales from awards, exercises and tax withholding, totals the flow per insider, flags 10b5-1 plans where the filing notes them, and hands you a cited write-up plus a downloadable transactions table.
Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.